Brief: Cellceutix loss per share $0.02
13/05/2015 12:00
May 13 (Reuters) - Cellceutix Corp CTIX.PK : * Reports results for quarter ended March 31, 2015; enrollment for oral mucositis studies to begin this month * Quarterly loss per share $0.02 * Source text for Eikon [ID:nMKWnG709a ] * Further company coverage CTIX.PK * ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Innovation Pharmaceuticals
See all newsBrief: Innovation Pharmaceuticals Announces New Milestone At Beamed On Track To File 510(K) Submission To FDA In Q2 2024
Brief: Innovation Pharmaceuticals Provides Update On US Patent Applications Covering Use Of Brilacidin In Inflammatory Bowel Diseases, Coronaviruses And Fungal Diseases
Brief: Innovation Pharma Reports Enrollment In Phase 2 Trial Of Brilacidin For COVID-19 Tops 70%
Brief: Innovation Pharma Surpasses 50% Enrollment In Phase 2 Clinical Trial Of Brilacidin For COVID-19
Brief: Innovation Pharma Completes Interim Safety Data Review